MEDICINES CO /DE Financial Statements (2025 and earlier)
Company Profile
| Business Address |
8 SYLVAN WAY PARSIPPANY, NJ 07054 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 323,700 | 202,100 | 240,937 | 131,800 | 183,572 | 240,483 | |||
| Cash and cash equivalent | 319,272 | 199,736 | 238,310 | 118,708 | 162,530 | 215,962 | |||
| Short-term investments | 4,407 | 2,353 | 2,627 | 13,089 | 21,042 | 24,521 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | 21 | 11 | 3 | ||||||
| Receivables | 2,899 | 7,740 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 1,098 | 864 | 866 | 3,689 | 4,757 | ||||
| Inventory | 1,098 | 864 | 866 | 3,689 | 4,757 | ||||
| Disposal group, including discontinued operation | 320 | ||||||||
| Other undisclosed current assets | 57,927 | 54,901 | 53,002 | 54,263 | 28,886 | 30,091 | |||
| Total current assets: | 381,627 | 258,099 | 294,803 | 187,249 | 219,046 | 283,071 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 32,696 | ✕ | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 7,874 | 8,372 | 8,872 | 10,091 | 15,818 | 16,533 | |||
| Intangible assets, net (including goodwill) | 200,571 | 200,571 | 200,571 | 200,571 | 200,571 | 200,571 | |||
| Goodwill | 200,571 | 200,571 | 200,571 | 200,571 | 200,571 | 200,571 | |||
| Restricted cash and investments | 6,532 | 6,709 | 6,710 | 5,410 | 5,433 | 5,543 | |||
| Other noncurrent assets | 35,170 | 36,296 | 4,924 | 4,610 | 28,762 | 28,920 | |||
| Other undisclosed noncurrent assets | 291,803 | 325,806 | 325,806 | 325,806 | 326,207 | 326,536 | |||
| Total noncurrent assets: | 574,646 | 577,754 | 546,883 | 546,488 | 576,791 | 578,103 | |||
| TOTAL ASSETS: | 956,273 | 835,853 | 841,686 | 733,737 | 795,837 | 861,174 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 56,397 | 55,599 | 58,411 | 58,513 | 80,058 | 105,202 | |||
| Accounts payable | 4,331 | 11,786 | 695 | 7,529 | 5,626 | 5,907 | |||
| Accrued liabilities | 52,066 | 43,813 | 57,716 | 50,984 | 74,432 | 99,295 | |||
| Debt | |||||||||
| Disposal group, including discontinued operation | 19,122 | ||||||||
| Business combination, contingent consideration, liability | 4,100 | 4,854 | |||||||
| Other liabilities | 7,567 | 7,546 | 122 | 259 | 397 | ||||
| Total current liabilities: | 63,964 | 63,145 | 58,411 | 77,757 | 84,417 | 110,453 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 31,319 | ||||||||
| Liabilities, other than long-term debt | 36,406 | 39,396 | 12,787 | 12,820 | 12,737 | 12,778 | |||
| Other liabilities | 36,406 | 39,396 | 12,787 | 12,820 | 12,737 | 12,778 | |||
| Operating lease, liability | 31,319 | ✕ | ✕ | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 786,455 | 808,701 | 792,752 | 669,724 | 677,454 | 670,287 | |||
| Total noncurrent liabilities: | 854,180 | 848,097 | 805,539 | 682,544 | 690,191 | 683,065 | |||
| Total liabilities: | 918,144 | 911,242 | 863,950 | 760,301 | 774,608 | 793,518 | |||
| Temporary equity, including noncontrolling interest | |||||||||
| Equity | |||||||||
| Equity, attributable to parent | 38,129 | (75,389) | (22,264) | (26,564) | 21,229 | 67,656 | |||
| Common stock | 82 | 77 | 77 | 76 | 76 | 76 | |||
| Treasury stock, value | (90,016) | (90,016) | (90,016) | (90,016) | (90,016) | (90,016) | |||
| Additional paid in capital | 1,633,308 | 1,460,545 | 1,452,975 | 1,406,229 | 1,398,377 | 1,390,484 | |||
| Accumulated other comprehensive loss | (4,601) | (5,406) | (4,576) | (4,605) | (4,594) | (4,471) | |||
| Accumulated deficit | (1,500,644) | (1,440,589) | (1,380,724) | (1,338,248) | (1,282,614) | (1,228,417) | |||
| Total equity: | 38,129 | (75,389) | (22,264) | (26,564) | 21,229 | 67,656 | |||
| TOTAL LIABILITIES AND EQUITY: | 956,273 | 835,853 | 841,686 | 733,737 | 795,837 | 861,174 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 800 | 1,667 | 7,771 | |||||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 7,771 | |
| Sublease income | 800 | ✕ | ✕ | ✕ | ✕ | |||
| Cost of revenue | (500) | (29,279) | (890) | (2,931) | (2,737) | |||
| Cost of product and service sold | (890) | (2,931) | (2,737) | |||||
| Gross profit: | 800 | (500) | (29,279) | (890) | (1,264) | 5,034 | ||
| Operating expenses | (48,001) | (43,493) | 3,547 | (44,635) | (51,307) | (69,317) | ||
| Other undisclosed operating loss | (800) | (3,300) | ||||||
| Operating loss: | (48,001) | (43,993) | (25,732) | (48,825) | (52,571) | (64,283) | ||
| Nonoperating income (expense) | 3,744 | 155 | (9,426) | (6,834) | (2,421) | (27,620) | ||
| Investment income, nonoperating | 2,057 | (266) | (10,465) | (7,953) | (3,474) | (29,989) | ||
| Other nonoperating income | 1,687 | 421 | 1,039 | 1,119 | 1,053 | 2,369 | ||
| Interest and debt expense | (15,791) | (16,024) | (12,913) | (12,313) | (12,108) | (12,077) | ||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (753) | 271 | 254 | 228 | ||||
| Loss from continuing operations before equity method investments, income taxes: | (60,048) | (59,862) | (48,824) | (67,701) | (66,846) | (103,752) | ||
| Other undisclosed income from continuing operations before income taxes | 1,019 | |||||||
| Loss from continuing operations before income taxes: | (60,048) | (59,862) | (47,805) | (67,701) | (66,846) | (103,752) | ||
| Income tax expense (benefit) | (7) | (3) | 3,513 | 16,066 | 12,393 | 18,916 | ||
| Loss from continuing operations: | (60,055) | (59,865) | (44,292) | (51,635) | (54,453) | (84,836) | ||
| Loss before gain (loss) on sale of properties: | (60,055) | (59,865) | (44,292) | (51,635) | (54,453) | (84,836) | ||
| Other undisclosed net income | 112,060 | |||||||
| Net income (loss): | (60,055) | (59,865) | 67,768 | (51,635) | (54,453) | (84,836) | ||
| Other undisclosed net income (loss) attributable to parent | (110,242) | (3,999) | 256 | 113,985 | ||||
| Net income (loss) available to common stockholders, diluted: | (60,055) | (59,865) | (42,474) | (55,634) | (54,197) | 29,149 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (60,055) | (59,865) | 67,768 | (51,635) | (54,453) | (84,836) | ||
| Other undisclosed comprehensive income | 607 | |||||||
| Comprehensive income (loss): | (60,055) | (59,865) | 68,375 | (51,635) | (54,453) | (84,836) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 805 | (830) | (110,820) | (4,010) | 133 | 114,697 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (59,250) | (60,695) | (42,445) | (55,645) | (54,320) | 29,861 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.